| 151 |
News & Events |
general |
Link |
| 152 |
News & Events |
general |
Link |
| 153 |
News & Events |
general |
Link |
| 154 |
News & Events |
general |
Link |
| 155 |
News & Events |
general |
Link |
| 156 |
News & Events |
general |
Link |
| 157 |
News & Events |
general |
Link |
| 158 |
News & Events |
general |
Link |
| 159 |
News & Events |
general |
Link |
| 160 |
News & Events |
general |
Link |
| 161 |
News & Events |
general |
Link |
| 162 |
Open Positions |
general |
Link |
| 163 |
Organization |
general |
Link |
| 164 |
Organization |
general |
Link |
| 165 |
Organization Chart |
general |
Link |
| 166 |
Other Questions |
general |
Link |
| 167 |
PEOPLEアイセムスの人々 |
general |
Link |
| 168 |
People |
general |
Link |
| 169 |
Phase 1 clinical trial of bosutinib for amyotrophic lateral sclerosis (ALS); iDReAM study｜News & Events |
general |
Link |
| 170 |
Phase II Clinical Trial Begins for Autosomal Dominant Polycystic Kidney Disease Drug Candidate Identified by iPS Cell-based Drug Discovery｜News & Events |
general |
Link |
| 171 |
Photo Galleries ｜ For the Public |
general |
Link |
| 172 |
Photo Galleries ｜ For the Public |
general |
Link |
| 173 |
Pinpointing TAF4B's critical contribution to blood lineage specification｜News & Events |
general |
Link |
| 174 |
Pioneering a cure for Parkinson's disease: First allogeneic iPS cell-based therapy demonstrates safety and efficacy｜News & Events |
general |
Link |
| 175 |
Poster awards at the 2024 CiRA Retreat! |
general |
Link |
| 176 |
Privacy Policy |
general |
Link |
| 177 |
Privacy Policy |
general |
Link |
| 178 |
Q.どんな分野やテーマで産学連携ができますか。 |
general |
Link |
| 179 |
Q.一般向け講座のオンライン受講、動画配信はありますか。 |
general |
Link |
| 180 |
Q.一般向け講座の申込方法や料金を教えてください。 |
general |
Link |